Vildagliptin

  • 132 trials, 3 about aging, 102 with no results posted
  • 92 of 132 trials sponsored by its developers
  • Human trial1
  • Humans1

Trials

3 about aging, of 132

Approved

  • EMA Galvus

    Sep 25, 2007Diabetes Mellitus, Type 2, Diabetes

  • EMA Jalra

    Nov 19, 2008Diabetes Mellitus, Type 2, Diabetes

  • EMA Xiliarx

    Nov 19, 2008Diabetes Mellitus, Type 2, Diabetes

Repurposing

All 25

Every condition in trials

  • Fasting

    Phase 4Completed1 trial

  • Fed condition

    Phase 1Completed1 trial

Stopped

  • NCT01910441TerminatedType 2 diabetes

    The study was terminated due to the unavailability of Continuous Glucose Monitoring sensors (CGMS) which were required to assess the primary end-point.

Trial sponsors

Latest